![Fei Shen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Fei Shen is the founder of ArrePath, Inc. Former jobs include Director at Rgenta Therapeutics, Inc., Managing Director at Boehringer Ingelheim (Venture Capital) from 2021 to 2026, and Head-In Vivo Pharmacology at Boehringer Ingelheim USA, Inc. from 2016 to 2020.
Education history includes a graduate degree from Eastern Illinois University in 2002, an undergraduate degree from East China University of Science & Technology in 1999, and a doctorate from Loyola University Chicago in 2007.
Posizioni attive di Fei Shen
| Società | Posizione | Inizio |
|---|---|---|
ArrePath, Inc.
 ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Fondatore | - |
Precedenti posizioni note di Fei Shen
| Società | Posizione | Fine |
|---|---|---|
Rgenta Therapeutics, Inc.
 Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pipeline of oral and small-molecule RNA-targeting medicines | Direttore/Membro del Consiglio | - |
Boehringer Ingelheim (Venture Capital)
 Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors. | Investitore di Private Equity | - |
Formazione di Fei Shen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Eastern Illinois University
 Eastern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim (Venture Capital)
Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors. | Finance |
Rgenta Therapeutics, Inc.
Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pipeline of oral and small-molecule RNA-targeting medicines | Health Technology |
ArrePath, Inc.
ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Health Technology |
